https://lirametostatinhibitor.....com/the-particular-p
Commercially insured children and adults with a COVID-19 analysis (situations) during April-August 2020 were matched to those without COVID-19 (controls) on a 14 proportion. Direct medical costs represented 1-, 3-, and 6-month complete expenditures per person starting 31 days after the analysis time. We utilized a 2-part design to guage price distinctions among individuals with and without COVID-19, adjusted for patient attributes. Expenses were higher among cases compared with settin
Like
Comment
Share
